Hematology deals with blood, blood-forming tissues, and the related cellular components. Modern-day analysis is performed primarily by automated instrumentation coupled with blood film interpretation. Analysis can identify cells associated with a wide variety of blood disorders such as leukemia and anemia. Hematology also includes investigating bleeding or coagulation disorders, such as hemophilia, and monitoring patients on anticoagulant therapies.
The Hematopathology Advisory Group applied their experience, knowledge and perspective from their practice of medicine to support the analysis of system gaps and develop improvement recommendations for the Agency’s Strategic Service Delivery Plan. The Agency will continue to use the perspective of subject matter experts to support future planning and implementation of Hematopathology recommendations.
Agency Executive invited six Hematopathologists to become part of the Hematopathology Advisory Group. The members include:
Dr. Michelle Wong, Medical Lead
Richard Walker, Strategic Lead
Dr. Brian Berry
Dr. Gerry James
Dr. Justin Lo
Dr. Robert Coupland
Dr. Tyler Smith
For questions about the Advisory Group, please email Dr. Michelle Wong, Medical Lead or Richard Walker, Strategic Lead.
